Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
出版年份 2015 全文链接
标题
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
作者
关键词
-
出版物
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Volume 182, Issue 1, Pages 35-44
出版商
Wiley
发表日期
2015-06-19
DOI
10.1111/cei.12667
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease
- (2015) Luca Cantarini et al. AUTOIMMUNITY REVIEWS
- Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
- (2015) Linda Rossi-Semerano et al. Orphanet Journal of Rare Diseases
- FRI0219 Disease severity, no steroid use and type ii diabetes predict response to anakinra (kineret®) in patients with rheumatoid arthritis
- (2014) B. Missler-Karger et al. ANNALS OF THE RHEUMATIC DISEASES
- The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
- (2014) Susana Vallejo et al. Cardiovascular Diabetology
- Increased Benefit of Interleukin-1 Inhibition on Vascular Function, Myocardial Deformation, and Twisting in Patients With Coronary Artery Disease and Coexisting Rheumatoid Arthritis
- (2014) Ignatios Ikonomidis et al. Circulation-Cardiovascular Imaging
- Markers of innate immune activity in patients with type 1 and type 2 diabetes mellitus and the effect of the anti-oxidant coenzyme Q10 on inflammatory activity
- (2014) H. Brauner et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Anakinra treatment in patients with gout and type 2 diabetes
- (2014) Antonio Vitale et al. CLINICAL RHEUMATOLOGY
- Caspases and inflammasomes in metabolic inflammation
- (2014) Alexander M Skeldon et al. IMMUNOLOGY AND CELL BIOLOGY
- Interleukin-1 Receptor Antagonist Originating from Bone Marrowderived Cells and Non-bone Marrow-derived Cells Helps to Suppress Arterial Inflammation and Reduce Neointimal Formation after Injury
- (2014) Kikuo Isoda et al. Journal of Atherosclerosis and Thrombosis
- Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
- (2014) E. Choy et al. RHEUMATOLOGY
- Cardiovascular Comorbidity in Rheumatic Diseases
- (2014) Kerry Wright et al. Heart Failure Clinics
- Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
- (2013) Rebeccah J Mathews et al. ANNALS OF THE RHEUMATIC DISEASES
- CD4+CD45RA−FoxP3highactivated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes
- (2013) F. Haseda et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Macrophages and islet inflammation in type 2 diabetes
- (2013) K. Eguchi et al. DIABETES OBESITY & METABOLISM
- Macrophages control innate inflammation
- (2013) S. Akira et al. DIABETES OBESITY & METABOLISM
- L-cysteine and hydrogen sulfide increase PIP3 and AMPK/PPARγ expression and decrease ROS and vascular inflammation markers in high glucose treated human U937 monocytes
- (2013) Prasenjit Manna et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
- (2013) A. Cas et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Mechanisms of disease: inflammasome activation and the development of type 2 diabetes
- (2013) Ryan W. Grant et al. Frontiers in Immunology
- Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies
- (2012) Juan Antonio Avina-Zubieta et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen
- (2012) Paul M Ridker et al. CIRCULATION
- Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
- (2012) Hye-Mi Lee et al. DIABETES
- Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
- (2012) K. P. Liao et al. RHEUMATOLOGY
- The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study
- (2012) Aamer Sandoo et al. ARTHRITIS RESEARCH & THERAPY
- Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
- (2011) Paul M Ridker et al. AMERICAN HEART JOURNAL
- Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation
- (2011) Ashley M. Miller et al. CURRENT PHARMACEUTICAL DESIGN
- Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
- (2011) Yun-Hee Youm et al. ENDOCRINOLOGY
- Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Edwin J. P. van Asseldonk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
- (2011) Haitao Wen et al. NATURE IMMUNOLOGY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammasome is a central player in the induction of obesity and insulin resistance
- (2011) R. Stienstra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
- (2010) D. H. Solomon et al. ANNALS OF THE RHEUMATIC DISEASES
- Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity
- (2010) D. H. Solomon et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Traditional cardiovascular risk factors in rheumatoid arthritis: A meta-analysis
- (2010) Jean-Frédéric Boyer et al. JOINT BONE SPINE
- Inflammation and Microvascular and Macrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Effect of Treatment
- (2010) W. FOSTER et al. JOURNAL OF RHEUMATOLOGY
- The NLRP3 Inflammasome: A Sensor for Metabolic Danger?
- (2010) K. Schroder et al. SCIENCE
- Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: Risk reduction in a chronic inflammatory disease
- (2010) Mary Chester Wasko et al. ARTHRITIS CARE & RESEARCH
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
- (2009) Young Hee Rho et al. ARTHRITIS AND RHEUMATISM
- Rheumatoid Arthritis
- (2009) Ivy A. Ku et al. CIRCULATION JOURNAL
- Standards of Medical Care in Diabetes--2010
- (2009) DIABETES CARE
- Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
- (2009) C. M. Larsen et al. DIABETES CARE
- Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis
- (2009) I Ikonomidis et al. HEART
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis
- (2008) Peter Libby AMERICAN JOURNAL OF MEDICINE
- Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis
- (2008) Sherine E. Gabriel AMERICAN JOURNAL OF MEDICINE
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies
- (2008) J. Antonio Aviña-Zubieta et al. ARTHRITIS AND RHEUMATISM
- Inhibition of Interleukin-1 by Anakinra Improves Vascular and Left Ventricular Function in Patients With Rheumatoid Arthritis
- (2008) Ignatios Ikonomidis et al. CIRCULATION
- Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study
- (2008) C. Herder et al. DIABETES CARE
- The Antiinflammatory Cytokine Interleukin-1 Receptor Antagonist Protects from High-Fat Diet-Induced Hyperglycemia
- (2008) Nadine S. Sauter et al. ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search